verapamil has been researched along with prednisolone in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (9.30) | 18.7374 |
| 1990's | 5 (11.63) | 18.2507 |
| 2000's | 19 (44.19) | 29.6817 |
| 2010's | 14 (32.56) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Baumann, K; Stiefl, N | 1 |
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Thakker, DR; Troutman, MD | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Akamatsu, M | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anner, BM; Gervais, A; Lane, LK; Lindenmayer, GE; Schwartz, A | 1 |
| Degiannis, D; Hornung, N; Raska, K; Raskova, J | 1 |
| Chazov, EI | 1 |
| Launchbury, AP | 1 |
| Fujii, J; Kato, K; Takahashi, N | 1 |
| Carozzi, S; Fontana, I; Nasini, MG; Nocera, A; Pietrucci, A; Valente, U | 1 |
| Hsu, CH; Robinson, CP | 1 |
| Degiannis, D; Hornung, N; Luke-Gustites, D; Raska, K; Raskova, J | 1 |
| Cunningham, D; Gore, M; Kulkarni, S; Mehta, J; Middleton, G; Milan, S; Millar, B; Powles, R; Raje, N; Raymond, J; Singhal, S; Treleaven, J; Viner, C | 1 |
| Koski, T; Vilpo, J; Vilpo, L | 1 |
| Evers, S; Frese, A; Husstedt, IW; Sörös, P | 1 |
| Dommerich, S; Graumüller, S; Hoff, M; Ostwald, J | 1 |
| de Paola, AA; Fenelon, G; Franco, M; Katchburian, E; Mora, O | 1 |
| Kumar, NS; Mishra, RN; Prakash, J; Singh, AK | 1 |
| Wyska, E | 1 |
| Hippalgaonkar, K; Majumdar, S; Srirangam, R | 1 |
| Avula, B; Hippalgaonkar, K; Khan, IA; Majumdar, S; Srirangam, R | 1 |
| Adeneye, AA; Akindele, AJ; Benebo, AS; Olatoye, F | 1 |
| Diener, HC; May, A | 1 |
4 review(s) available for verapamil and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Treatment of arrhythmia in myocardial infarct].
Topics: Amides; Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Cardiac Complexes, Premature; Cardiac Glycosides; Glucose; Humans; Injections, Intramuscular; Injections, Intravenous; Insulin; Myocardial Infarction; Phytotherapy; Plants, Medicinal; Potassium; Prednisolone; Procaine; Propranolol; Pyridoxine; Rauwolfia; Strophanthins; Sympathomimetics; Tachycardia, Paroxysmal; Thiamine; Thiamine Pyrophosphate; Ventricular Fibrillation; Verapamil; Water-Electrolyte Balance | 1968 |
Some recently introduced drugs.
Topics: Amidines; Anti-Bacterial Agents; Antidepressive Agents; Antihypertensive Agents; Bronchodilator Agents; Chemical Phenomena; Chemistry; Clopamide; Drug Therapy; Ethacrynic Acid; Expectorants; Glycolates; Humans; Indoles; Neuromuscular Nondepolarizing Agents; Penicillin G; Pentazocine; Prednisolone; Prenylamine; Propanidid; Quinolines; Rifampin; Sympatholytics; Verapamil | 1970 |
Drug Treatment of Cluster Headache.
Topics: Cluster Headache; Drug Administration Routes; Humans; Lithium; Oxazolidinones; Oxygen Inhalation Therapy; Prednisolone; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Tryptamines; Verapamil | 2022 |
3 trial(s) available for verapamil and prednisolone
| Article | Year |
|---|---|
Immunosuppressive effects of different calcium channel blockers in human kidney allografts.
Topics: Calcium; Calcium Channel Blockers; Cyclosporine; Cytokines; Diltiazem; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Isradipine; Kidney Transplantation; Lymphocytes; Prednisolone; Transplantation, Homologous; Verapamil | 1995 |
A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Prednisolone; Survival Rate; Transplantation, Autologous; Treatment Outcome; Verapamil; Vincristine | 1997 |
Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Child; Drug Resistance; Female; Glucocorticoids; Humans; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Ramipril; Verapamil | 2004 |
36 other study(ies) available for verapamil and prednisolone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
Topics: Acetates; Alcohols; Algorithms; Cholinergic Agents; Hydrocarbons, Acyclic; Hydrocarbons, Aromatic; Ketones; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship; Receptor, Muscarinic M2; Receptors, Muscarinic; Steroids; Transcortin | 2003 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blotting, Western; Cells, Cultured; Diffusion; Humans; Intestinal Absorption; Intestinal Mucosa; Models, Biological; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A possible molecular mechanism of the action of digitalis: ouabain action on calcium binding to sites associated with a purified sodium-potassium-activated adenosine triphosphatase from kidney.
Topics: Adenosine Triphosphatases; Adsorption; Animals; Binding Sites; Binding, Competitive; Calcium; In Vitro Techniques; Kidney; Kinetics; Lanthanum; Magnesium; Ouabain; Phospholipases; Phospholipids; Potassium; Prednisolone; Protein Denaturation; Sheep; Sodium; Verapamil | 1977 |
IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants.
Topics: CD4 Antigens; CD8 Antigens; Cyclosporine; Egtazic Acid; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Prednisolone; Receptors, Interleukin-2; Recombinant Proteins; T-Lymphocytes; Verapamil | 1992 |
The bradycardia-tachycardia syndrome. Treatment with cardiac drugs and adrenal corticosteroid.
Topics: Adolescent; Aged; Atropa belladonna; Bradycardia; Electrocardiography; Female; Heart Block; Heart Conduction System; Humans; Male; Metaproterenol; Middle Aged; Pacemaker, Artificial; Phytotherapy; Plants, Medicinal; Plants, Toxic; Prednisolone; Syndrome; Tachycardia; Verapamil | 1973 |
Terbutaline-induced desensitization in rabbit aorta in vitro.
Topics: Adenosine; Animals; Aorta; Calcium; Isoproterenol; Ketotifen; Male; Nedocromil; Phenylephrine; Prednisolone; Rabbits; Receptors, Adrenergic, beta; Terbutaline; Vasoconstriction; Verapamil | 1993 |
IL-4 receptor expression by SAC-activated B-lymphocytes: its role in B-cell proliferation and the effect of cyclosporine (CsA), prednisolone and verapamil.
Topics: B-Lymphocytes; Cell Division; Cyclosporine; Humans; In Vitro Techniques; Interleukin-4; Lymphocyte Activation; Prednisolone; Receptors, Interleukin-4; Receptors, Mitogen; Staphylococcus aureus; Verapamil | 1993 |
Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; B-Lymphocytes; Calcium; Calcium Channel Blockers; Calcium Signaling; Chlorambucil; Cisplatin; Cladribine; Cyclosporine; DNA Fragmentation; Doxorubicin; Drug Synergism; Female; Flow Cytometry; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nifedipine; Prednisolone; Tumor Cells, Cultured; Verapamil; Vidarabine; Vincristine | 2000 |
Cluster headache after dental extraction: implications for the pathogenesis of cluster headache?
Topics: Anti-Inflammatory Agents; Calcium Channel Blockers; Causalgia; Cluster Headache; Drug Therapy, Combination; Female; Humans; Hypothalamus; Lithium Carbonate; Male; Middle Aged; Molar; Molar, Third; Nerve Fibers; Oxygen; Postoperative Period; Prednisolone; Respiratory Therapy; Tooth Extraction; Trigeminal Nerve Injuries; Verapamil | 2001 |
[Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Androstadienes; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Beclomethasone; Calcium Channel Blockers; Cells, Cultured; Culture Media; Diclofenac; Fibroblasts; Fluticasone; Glucocorticoids; Hematologic Agents; Humans; In Vitro Techniques; Mesalamine; Methylprednisolone; Mometasone Furoate; Muscarinic Agonists; Nasal Polyps; Pentoxifylline; Pilocarpine; Piroxicam; Prednisolone; Pregnadienediols; Time Factors; Timolol; Verapamil | 2003 |
Combined therapy with steroids and antioxidants prevents ultrastructural damage surrounding chronic radiofrequency lesions.
Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Antioxidants; Catheter Ablation; Dogs; Drug Therapy, Combination; Heart Atria; Heart Ventricles; Hydrocortisone; Male; Prednisolone; Steroids; Verapamil; Wound Healing | 2004 |
Pretreatment with R(+)-verapamil significantly reduces mortality and cytokine expression in murine model of septic shock.
Topics: Animals; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytokines; Drug Synergism; Lipopolysaccharides; Liver; Lung; Male; Mice; Pentoxifylline; Prednisolone; Shock, Septic; Verapamil | 2009 |
Vitreal kinetics of quinidine in rabbits in the presence of topically coadministered P-glycoprotein substrates/modulators.
Topics: Administration, Topical; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Drug Interactions; Erythromycin; Fluorescein; Fluorescent Dyes; Half-Life; Male; Metabolic Clearance Rate; Ophthalmic Solutions; Prednisolone; Quinidine; Rabbits; Tissue Distribution; Verapamil; Vitreous Body | 2009 |
Interaction between topically and systemically coadministered P-glycoprotein substrates/inhibitors: effect on vitreal kinetics.
Topics: Administration, Topical; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Injections, Intravenous; Male; Mass Spectrometry; Microdialysis; Ophthalmic Solutions; Prednisolone; Quinidine; Rabbits; Substrate Specificity; Time Factors; Tissue Distribution; Verapamil; Vitreous Body | 2010 |
Protective effect of selected calcium channel blockers and prednisolone, a phospholipase-A2 inhibitor, against gentamicin and carbon tetrachloride-induced nephrotoxicity.
Topics: Animals; Antioxidants; Biomarkers; Calcium Channel Blockers; Carbon Tetrachloride; Cytoprotection; Diltiazem; Disease Models, Animal; Gentamicins; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Nifedipine; Oxidative Stress; Phospholipase A2 Inhibitors; Prednisolone; Rats, Wistar; Time Factors; Verapamil | 2014 |